Product Information
OXYBUTYNIN CL ER 15 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1169 per EA under NDC 64980021101. Its NADAC has been published 495 times since Jan 4, 2017.
The High Outlier badge above means this manufacturer's average price in the Oxybutynin Chloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980021101
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206121On Market Since
9/27/2016
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 15 MG TABLET has been published 495 times since Jan 4, 2017, and over the history we have for it it has declined 86.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1169 per EA |
|---|---|
| All-time high | $0.8594 (Jan 11, 2017) |
| All-time low | $0.0936 (Apr 17, 2024) |
| 52-week high | $0.1456 |
| 52-week low | $0.1161 |
| Median price | $0.2477 |
| Average price | $0.2906 |
| Largest weekly change | +38.9% (May 22, 2024) |
| Weeks tracked | 495 |
| Tracking since | Jan 4, 2017 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 15 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1169 per EA (NDC 64980021101), effective Jun 24, 2026.
How has the price of OXYBUTYNIN CL ER 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has declined 86.4%. It has been tracked across 495 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 15 MG TABLET?
Since Jan 4, 2017, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has ranged from a low of $0.0936 (Apr 17, 2024) to a high of $0.8594 (Jan 11, 2017), with a median of $0.2477 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 15 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OXYBUTYNIN CL ER 15 MG TABLET, is $0.1161 per EA — about 1% below OXYBUTYNIN CL ER 15 MG TABLET.
Who manufactures OXYBUTYNIN CL ER 15 MG TABLET?
OXYBUTYNIN CL ER 15 MG TABLET (NDC 64980021101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification